Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from DaVita

Are Wall Street Analysts Predicting DaVita Stock Will Climb or Sink?

While DaVita has outperformed relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Two Of 2024's Best Stocks Rule The Market Yet Again This Year

Two Of 2024's Best Stocks Rule The Market Yet Again This Year

If an S&P 500 stock has one good year — that could be just luck, right? How about if the stock repeats its good fortune?

Investors Business Daily

DaVita Earnings Preview: What to Expect

DaVita Earnings Preview: What to Expect

DaVita is set to announce its fourth-quarter results next month, with analysts forecasting a double-digit growth in the company’s bottom-line figure.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

DaVita Shows Market Leadership With Jump To 84 RS Rating

A Relative Strength Rating upgrade for DaVita shows improving technical performance.

Investors Business Daily

DaVita Stock: Is DVA Outperforming the Healthcare Sector?

Despite DaVita’s recent outperformance relative to its broader sector, Wall Street analysts remain cautious about the stock’s prospects.

DaVita Stock Sees Improved Relative Strength Rating

A Relative Strength Rating upgrade for DaVita shows improving technical performance. Will it continue?

Investors Business Daily

CEOs share the big project that landed them in corner office

CEOs spoke to Fortune about the big projects and skills that helped place them in the corner office.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is Wall Street Bullish or Bearish on DaVita Stock?

Is Wall Street Bullish or Bearish on DaVita Stock?

While DaVita has outperformed the broader market over the past year, analysts on Wall Street are exercising caution regarding its future prospects.

Apple, Top Warren Buffett Stocks Slip — As This Giant Breaks Out

Apple, Top Warren Buffett Stocks Slip — As This Giant Breaks Out

This week marks a fire hose of earnings from top Berkshire Hathaway equity holdings. Amazon and Apple included.

Investors Business Daily

6 Stocks Dominate Market's 'Best 6 Months' — Starting This Week

6 Stocks Dominate Market's 'Best 6 Months' — Starting This Week

If you had to choose the best time to invest in the S&P 500 — it's the six months starting in November.

Investors Business Daily

What to Expect From DaVita's Next Quarterly Earnings Report

What to Expect From DaVita's Next Quarterly Earnings Report

DaVita is all set to release its third-quarter earnings this month, and analysts expect a single-digit profit dip.

Nvidia And This Breakout IPO Lead Elite List Of Stocks To Watch

Nvidia And This Breakout IPO Lead Elite List Of Stocks To Watch

Nvidia stock leads crop of IBD Leaderboard stocks to watch, including DoorDash, DaVita and one IPO stock that has cruised into buy range.

Investors Business Daily

1 Outperforming Warren Buffett Stock That Still Looks Undervalued

1 Outperforming Warren Buffett Stock That Still Looks Undervalued

This healthcare pick has outperformed the broader market in 2024, but is still priced at a discount.

Is DaVita Stock Outperforming the Dow?

Is DaVita Stock Outperforming the Dow?

Although DaVita has outperformed the Dow Jones Industrials Average, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall With Inflation Data On Tap; Trump Stock Dives After Presidential Debate

Futures fell while Donald Trump stock DJT dived after the Trump-Harris debate Tuesday night. The CPI inflation report is due before the open.

Investors Business Daily

Why IBD Stock Of The Day DaVita Spent A Month In A Buy Zone

DaVita stock is Tuesday's IBD Stock Of The Day. Shares have lingered in a buy zone for a month, buoyed by strong earnings growth.

Investors Business Daily

Dow Jones Futures Fall: Jobs Report Stakes High As Indexes Lose Support; AI Giant Broadcom Dives

The jobs report looms large as the stock market struggles at key levels. AI giant Broadcom tumbled overnight.

Investors Business Daily

Nvidia Gets Spanked To Start September, But This Stock Stays Fresh

A roller-coaster summer continues for Nvidia stock, while Freshpet leads a brigade of breakout stocks to watch.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Surges As Trump Stock Breaches Key Level; These Warren Buffett Picks Are Near Entries (Live Coverage)

The Dow Jones rose on the stock market today but a Donald Trump stock dived. Some Warren Buffett stocks are near entries. Nvidia rose.

Are Wall Street Analysts Bullish on DaVita Stock?

DaVita has surpassed the broader market over the past year, and Wall Street analysts are cautious about the stock’s prospects.

Investors Business Daily

Breakout Watch: Medical Stock In Buy Range, Notches All-Time High

DaVita stock launches a breakout to an all-time high as 44 A+ funds report a position in the kidney care leader.

What to Expect From DaVita's Q2 2024 Earnings Report

DaVita is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit increase.

Investors Business Daily

Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Flashes A Sell Signal

Tandem Diabetes stock rocketed Friday after the insulin pump-maker topped first quarter expectations. But DaVita stock reversed lower.

Investors Business Daily

How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher

ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.

Investors Business Daily

Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News

DaVita stock launched Tuesday after Novo Nordisk unveiled the results of its weight-loss drug in kidney disease patients.

People

Margaret Kaczor Andrew

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

248,745 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play